Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. - Wikidata - wikimedia - TriplyDB

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.

http://www.wikidata.org/entity/Q37578483

about

Preventive treatments for breast cancer: recent developments Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers Current condition of genetic medicine for hereditary breast cancer.BRCA1 and BRCA2 mutations and treatment strategies for breast cancer.High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer.Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.Impact of Prophylactic Mastectomy in BRCA1/2 Mutation Carriers Contralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies.Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias.The Manchester guidelines for contralateral risk-reducing mastectomy The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer Bilateral Mastectomy for Unilateral Breast Cancer: a Perplexing Trend Contralateral prophylactic mastectomy and its impact on quality of life Attitudes to contralateral risk reducing mastectomy among breast and plastic surgeons in England.Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer.A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriers.Genetic testing today.Ethics and genomic medicine, how to navigate decisions in surgical oncology.Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers.The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients.Women at familial risk of breast cancer electing for prophylactic mastectomy: frequencies, procedures, and decision-making characteristics.The Role of Knowledge on Genetic Counseling and Testing in Black Cancer Survivors at Increased Risk of Carrying a BRCA1/2 Mutation.Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer: The POSH Observational Cohort Study.Assessing, Counseling, and Treating Patients at High Risk for Breast Cancer.Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2015 edition.Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trial.Negative Genetic Testing Does Not Deter Contralateral Prophylactic Mastectomy in Younger Patients with Greater Family Histories of Breast Cancer.Preoperative genetic testing impacts surgical decision making in BRCA mutation carriers with breast cancer: a retrospective cohort analysis Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis.Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer.Survival analysis of contralateral prophylactic mastectomy: a question of selection bias.Integrating surgery and genetic testing for the modern surgeon.Evaluation of Breast Cancer Patients with Genetic Risk in a University Hospital: Before and After the Implementation of a Heredofamilial Cancer Unit.Local delivery of hormonal therapy with silastic tubing for prevention and treatment of breast cancer.Short report: Follow-up of Bahamian women with a BRCA1 or BRCA2 mutation.

P2860

Q27025375-B0F9926F-9CDB-4D11-8B3B-D3F29284F432 Q30896495-B2DCC0D0-07CF-4A97-B774-2A4B6758FCA3 Q31118195-860D77D6-C237-434D-888A-84887175F147 Q33823472-90796F51-0864-4319-BF9D-EFE3375821B8 Q33858408-55E9F08E-515F-46EB-B4C8-B885A9F055A8 Q33894431-A1EE3449-50D8-402B-8BD1-B47AA1289F58 Q34240064-4A619D9D-3432-402F-B419-25C471766CD2 Q34996647-A8CDD57C-3BE0-4089-8020-D00C319E7A4E Q35050959-662DCE9A-EACE-4616-AF6D-801AB0E0DDE9 Q35066801-3E883F8A-3B9A-45D6-A68C-F4A5BED9B2DE Q35850183-D4E57BE3-CE54-4F84-A340-A00244CC607E Q35923270-4425DC58-9AB2-451D-8616-E404F96AA018 Q35940364-56C55BF4-7BD5-4C7A-875F-1E12EE5B454A Q36734744-47EE5397-115C-4D63-ABAB-7F8B8D3DB070 Q37147521-C536D62B-5290-4250-B3CE-9C77D237F0F9 Q37556568-21D444BF-AEE0-426E-AE56-314249AF85A6 Q37710168-60D122E1-B268-4B37-BC07-049D1CA81E1A Q37719595-A98A6D55-94C9-4A2A-B214-D41247403121 Q38230196-DD69D286-5376-4DCF-8281-1AEF65D244DB Q38245663-FBFCB67C-AD40-488B-A59B-29F0A4400A00 Q38378750-C76F570C-D191-468D-B0CC-6CF64B0809C1 Q38777240-F7F96A3E-1F73-4E2C-9F26-6A8C81CD664A Q38821731-F89C9034-06ED-46D5-A691-BD45D718FB0D Q38842957-932D48DF-B76D-4CC3-B418-A370B4C8DF1A Q38846562-51A7978F-C7C2-4099-A70E-E13CA43CED7F Q39150355-2928F3C2-264C-4CBF-9895-E24B6A546633 Q39562817-BB06E068-3A88-4D4A-8DFF-C75800E71396 Q39612960-82782D1F-F2CE-4606-9D57-215EA65E468B Q39659182-66B52111-C433-4F8E-8F39-9AFC94ECF434 Q40912150-E34E841B-8E32-4F18-8179-1B3E6DA29E87 Q41024301-E947D9C2-E3BD-4397-A6F2-3E3115509556 Q41088085-5C0BD1D1-A36D-424B-8D71-AFB74ED96AB2 Q41146968-8A1BF939-EDC6-4C21-B0E5-DB678EBC5EF0 Q41517367-9AF445D2-7C71-4D5D-A5C3-AB819D225A78 Q44429695-EF9EF75D-CFED-427D-9AEF-6A8E9637519D Q46442172-6E8AE1BE-3CEF-4F45-9E28-92637ECAF20B Q47117168-CD3F4B0C-F14F-4FEF-990F-FE246A9190BC Q47191699-E680FB67-4298-4BF4-82C2-E38FC11EF4AE Q47192770-639C7108-E530-4868-9D99-F817BFAB3F95 Q47561619-B68BB0B8-62F6-4C6A-922D-CE66C00C5108

P2860

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.

http://www.wikidata.org/entity/Q37578483

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Contralateral mastectomy and s ...... tions: retrospective analysis.

@en

Contralateral mastectomy and s ...... tions: retrospective analysis.

@nl

type

label

Contralateral mastectomy and s ...... tions: retrospective analysis.

@en

Contralateral mastectomy and s ...... tions: retrospective analysis.

@nl

prefLabel

Contralateral mastectomy and s ...... tions: retrospective analysis.

@en

Contralateral mastectomy and s ...... tions: retrospective analysis.

@nl

P1433

Q37578483-2413DDD4-2F32-4F23-9561-AB2EA772B727

P1476

Q37578483-23042B31-7D27-488B-98AF-365EA5A64969

P2093

Q37578483-065C64B4-B06D-4528-9ACB-E47C8A652B9A

Q37578483-13054B98-7574-4425-9AC0-812540F9537E

Q37578483-248C4E90-C0E9-4E37-A389-3D611A3C1BBC

Q37578483-41540834-34A6-45AD-AA89-EBAB9C535963

Q37578483-8340B951-4FDD-4A8D-A107-1BA27BD758B3

Q37578483-8D405059-7C03-4424-9543-3DBFDC431701

Q37578483-9B349DBA-DAFE-44F8-A057-47299FFADAF1

Q37578483-A5B0F0B1-E93C-4C62-AEC3-B35438E3679B

Q37578483-E472D8C9-28EA-4A76-A560-5FAB728D0857

Q37578483-F43B62FE-D6A1-4A8A-9B1B-FF832EF30DFF

P2860

Q37578483-228480BE-799F-429C-A731-108E99C1F1DC

Q37578483-3B943201-E513-4384-8C2D-9778997799FF

Q37578483-4332736A-29AB-4BD9-BD37-34D71A676DC8

Q37578483-552FADE3-F380-4627-9695-97B2ECB46783

Q37578483-5D75A485-2438-413E-A299-EA336E37DD3A

Q37578483-73D38A15-CE41-44EB-B06F-8A0904AFF0A4

Q37578483-807BAF63-99DE-4BAC-8F69-3C96E1A0C282

Q37578483-9586D1E2-3D65-4B2E-827A-9E13896EEEEA

Q37578483-98E824E3-FF2F-4F9A-956B-ABE517527220

Q37578483-A1586E5F-681B-4482-B8AB-B684A74AF380

P304

Q37578483-67D07325-FE81-4B1F-82E6-2B216D46185B

P31

Q37578483-89C09E03-E379-4E34-8F22-29F9E5120B50

P356

Q37578483-77AAFD00-D2A9-40D3-A5D5-75BB25195344

P407

Q37578483-6B70772A-1C9D-4A1B-AC2B-54B81D51A742

P478

Q37578483-84177953-695D-4E83-90AD-1B7F16A8A616

P50

Q37578483-0D677330-0F89-415F-8D56-6076F63CA724

Q37578483-8066E83E-DDE3-43A4-90F9-7022B6296FC3

P577

Q37578483-FD1275F5-0924-4B71-B569-31CF18B21551

P5875

Q37578483-F5B8B073-E9B5-456E-ABFA-2EBBB010413C

P698

Q37578483-3DC92FE8-166D-4151-9A86-E178C6C73B72

P932

Q37578483-B6853A1D-ADD2-444B-ADB8-54DA6F6EF65D

P356

P1433

P1476

Contralateral mastectomy and s ...... tions: retrospective analysis.

@en

P2093

Andrea Eisen

http://www.w3.org/2001/XMLSchema#string

Barry Rosen

http://www.w3.org/2001/XMLSchema#string

Carrie Snyder

http://www.w3.org/2001/XMLSchema#string

Charmaine Kim-Sing

http://www.w3.org/2001/XMLSchema#string

Henry T Lynch

http://www.w3.org/2001/XMLSchema#string

Kelly Metcalfe

http://www.w3.org/2001/XMLSchema#string

Nadine Tung

http://www.w3.org/2001/XMLSchema#string

Parviz Ghadirian

http://www.w3.org/2001/XMLSchema#string

Ping Sun

http://www.w3.org/2001/XMLSchema#string

Shelley Gershman

http://www.w3.org/2001/XMLSchema#string

P2860

Prophylactic mastectomy for the prevention of breast cancer

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

Triple-negative breast cancer: clinical features and patterns of recurrence.

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis.

Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer.

P304

g226

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.G226

http://www.w3.org/2001/XMLSchema#string

P407

P478

348

http://www.w3.org/2001/XMLSchema#string

P50

William D Foulkes

Steven A. Narod

P577

2014-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260150018

http://www.w3.org/2001/XMLSchema#string

P698

24519767

http://www.w3.org/2001/XMLSchema#string

P932

3921438

http://www.w3.org/2001/XMLSchema#string